Article
Journal of Medicinal Chemistry, 2010, Vol. 53, No. 15 5605
(6) Johnson, D. E.; Russell, R. G.; Lockatell, C. V.; Zulty, J. C.;
Warren, J. W.; Mobley, H. L. T. Contribution of Proteus mirabilis
urease to persistence, urolithiasis, and acute pyelonephritis in a
mouse model of ascending urinary tract infection. Infect. Immun.
1993, 61, 2748–2754.
(7) Soriano, F.; Tauch, A. Microbiology and clinical features of
Corynebacterium urealyticum: urinary tract stones and genomics
as the rosetta stone. Clin. Microbiol. Infect. 2008, 14, 632–643.
(8) Worcester, E. M.; Coe, F. L. Nephrolithiasis. Primary Care 2008,
35, 369–391.
(32) Kobashi, K.; Takebe, S.; Numata, A. Specific inhibition of urease
by N-acylphosphoric triamides. J. Biochem. (Tokyo) 1985, 98,
1681–1688.
(33) Kobashi, K.; Hase, J.; Uehare, K. Specific inhibition of urease by
hydroxamic acids. Biochim. Biophys. Acta 1962, 65, 380–383.
(34) Hase, J.; Kobashi, K. Inhibition of Proteus vulgaris urease by
hydroxamic acids. J. Biochem. (Tokyo) 1967, 62, 293–299.
(35) Odake, S.; Nakahashi, K.; Morikawa, T.; Takebe, S.; Kobashi, K.
Inhibition of urease activity by dipeptidyl hydroxamic acids. Chem.
Pharm. Bull. (Tokyo) 1992, 40, 2764–2768.
(9) Goto, T.; Nakame, Y.; Nishida, M.; Ohi, Y. Bacterial biofilms and
catheters in experimental urinary tract infection. Int. J. Antimicrob.
Agents 1999, 11, 227–231.
(36) Kobashi, K.; Kumaki, K.; Hase, J. Effect of acyl residues of
hydroxamic acids on urease inhibition. Biochim. Biophys. Acta
1971, 227, 429–441.
(10) Jacobsen, S. M.; Stickler, D. J.; Mobley, H. L. T.; Shirtliff, M. E.
Complicated catheter associated urinary tract infections due to
Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 2008,
21, 26–59.
(11) Mobley, H. L.; Warren, J. W. Urease-positive bacteria and ob-
struction of long-term urinary catheters. J. Clin. Microbiol. 1987,
25, 2216–2217.
(37) Kobashi, K.; Takebe, S.; Terashima, N.; Hase, J. Inhibition of
urease activity by hydroxamic acid derivatives of amino acids.
J. Biochem. (Tokyo) 1975, 77, 837–843.
(38) Dixon, N. E.; Gazzola, C.; Watters, J. J.; Blakeley, R. L.; Zerner, B.
Inhibition of jack bean urease (EC 3.5.1.5) by acetohydroxamic
acid and by phosphoramidate. Equivalent weight for urease. J. Am.
Chem. Soc. 1975, 97, 4130–4131.
(12) Miano, R.; Germani, S.; Vespasiani, G. Stones and urinary tract
infections. Urol. Int. 2007, 79, 32–36.
(39) Kumaki, K.; Tomoka, S.; Kobashi, K.; Hase, J. Structure-activity
correlations between hydroxamic acids and their inhibitory powers
on urease activity. I. A quantitative approach to the effect of
hydrophobic character of acyl residue. Chem. Pharm. Bull. 1972,
20, 1599–1606.
(40) Jabri, E.; Carr, M. B.; Hausinger, R. P.; Karplus, P. A. The crystal
structure of urease from Klebsiella aerogenes. Science 1995, 268,
998–1004.
(13) Eslick, G. D. Helicobacter pylori infection causes gastric cancer? A
review of the epidemiological, meta-analytic, and experimental
evidence. World J. Gastroenterol. 2006, 12, 2991–2999.
(14) Amieva, M. R.; El-Omar, E. M. Host-bacterial interactions in
Helicobacter pylori infection. Gastroenterology 2008, 134, 306–323.
(15) Andersen, L. P. Colonization and infection by Helicobacter pylori
in humans. Helicobacter 2007, 12, 12–15.
(16) Amieva, M. R.; Salama, N. R.; Tompkins, L. S.; Falkow, S.
Helicobacter pylori enter and survive within multivesicular va-
cuoles of epithelial cells. Cell. Microbiol. 2002, 4, 677–690.
(17) Morris, N. S.; Stickler, D. J. The effect of urease inhibitors on the
encrustation of urethral catheters. Urol. Res. 1998, 26, 275–279.
(18) Jerusik, R. J.; Kadis, S.; Chapman, W. L.; Wooley, R. E. Influence
of acetohydroxamic acid on experimental Corynebacterium renale
pyelonephritis. Can. J. Microbiol. 1977, 23, 1448–1455.
(19) Griffith, D. P.; Khonsari, F.; Skurnick, J. H.; James, K. E. A
randomized trial of acetohydroxamic acid for the treatment and
prevention of infection-induced urinary stones in spinal cord injury
patients. J. Urol. 1988, 140, 318–324.
(20) Satoh, M.; Munakata, K.; Takeuchi, H.; Yoshida, O.; Takebe, S.;
Kobashi, K. Effects of a novel urease inhibitor, N(diaminophos-
phinyl)isopentenoylamide on the infection stone in rats. Chem.
Pharm. Bull. 1991, 39, 897–899.
(21) Satoh, M.; Munakata, K.; Takeuchi, H.; Yoshida, O.; Takebe, S.;
Kobashi, K. Evaluation of effects of novel urease inhibitor,
N-(pivaloyl)glycinohydroxamic acid on the formation of an infec-
tion bladder stone using a newly designed urolithiasis model in rats.
Chem. Pharm. Bull. 1991, 39, 894–896.
(22) Sivapriya, K.; Suguna, P.; Banerjee, A.; Saravanan, V.; Rao, D. N.;
Chandrasekaran, S. Facile one-pot synthesis of thio and selenourea
derivatives: A new class of potent urease inhibitors. Bioorg. Med.
Chem. Lett. 2007, 17, 6387–6391.
(23) Uesato, S.; Hashimoto, Y.; Nishino, M.; Nagaoka, Y.; Kuwajima,
H. N-Substituted hydroxyureas as urease inhibitors. Chem. Pharm.
Bull. (Tokyo) 2002, 50, 1280–1282.
(24) Ambrose, J. F.; Kistiakowsky, G. B.; Kridl, A. G. Inhibition of
urease by sulfur compounds. J. Am. Chem. Soc. 1950, 72, 317–321.
(25) Benini, S.; Rypniewski, W. R.; Wilson, K. S.; Ciurli, S.; Mangani,
S. The complex of Bacillus pasteurii urease with β-mercaptoethanol
from X-ray data at 1.65-A resolution. J. Biol. Inorg. Chem. 1998, 3,
268–273.
(41) Jabri, E.; Karplus, P. A. Structures of the Klebsiella aerogenes
urease apoenzyme and two active-site mutants. Biochemistry 1996,
35, 10616–10626.
(42) Pearson, M. A.; Michel, L. O.; Hausinger, R. P.; Karplus, P. A.
Structures of Cys319 variants and acetohydroxamate-inhibited
Klebsiella aerogenes urease. Biochemistry 1997, 36, 8164–8172.
(43) Pearson, M. A.; Hausinger, R. P.; Karplus, P. A. Crystallographic
studies of the nickel metalloenzyme urease and insights into the
catalytic mechanism. J. Inorg. Biochem. 1997, 67, 179–179.
(44) Benini, S.; Rypniewski, W. R.; Wilson, K. S.; Miletti, S.; Ciurli, S.;
Mangani, S. A new proposal for urease mechanism based on the
crystal structures of the native and inhibited enzyme from Bacillus
pasteurii: why urea hydrolysis costs two nickels. Structure Fold.
Des. 1999, 7, 205–216.
(45) Benini, S.; Rypniewski, W. R.; Wilson, K. S.; Miletti, S.; Ciurli, S.;
Mangani, S. The complex of Bacillus pasteurii urease with acet-
ohydroxamate anion from X-ray data at 1.55 A resolution. J. Biol.
Inorg. Chem. 2000, 5, 110–118.
(46) Ham, N. C.; Oh, S. T.; Sung, J. Y.; Cha, K. A.; Lee, M. H.; Oh,
B. H. Supramolecular assembly and acid resistance of Helicobacter
pylori urease. Nature Struct. Biol. 2001, 8, 505–509.
(47) Benini, S.; Rypniewski, W. R.; Wilson, K. S.; Mangani, S.; Ciurli,
S. Molecular details of urease inhibition by boric acid: insights into
the catalytic mechanism. J. Am. Chem. Soc. 2004, 126, 3714–3715.
(48) Vassiliou, S.; Grabowiecka, A.; Kosikowska, P.; Yiotakis, A.;
Kafarski, P.; Berlicki, Ł. Design, synthesis and evaluation of novel
organophosphorus inhibitors of bacterial ureases. J. Med. Chem.
2008, 51, 5736–5744.
(49) Cook, R.; Metini, M. The acid-catalyzed hydrolysis of phosphi-
nates. IV. Pentacoordinate intermediate formation during hydro-
lysis of a phosphinothionate. Can. J. Chem. 1985, 63, 3155–3159.
€
(50) Bohm, H.-J. The computer program LUDI: a new method for the
de novo design of enzyme inhibitors. J. Comput.-Aided Mol. Des.
1992, 6, 61–78.
€
(51) Bohm, H.-J. LUDI: rule-based automatic design of new substitu-
(26) Ashiralieva, A.; Kleiner, D. Polyhalogenated benzo- and naphtho-
quinones are potent inhibitors of plant and bacterial ureases. FEBS
Lett. 2003, 555, 367–370.
(27) Zaborska, W.; Kot, M.; Superata, K. Inhibition of Jack Bean
urease by 1,4-benzoquinone and 2,5-dimethyl-1,4-benzoquinone.
Evaluation of the inhibition mechanism. J. Enzyme Inhib. Med.
Chem. 2002, 17, 247–253.
(28) Zaborska, W.; Krajewska, B.; Leszko, M.; Olech, Z. Inhibition of
urease by Ni2þ ions: analysis of reaction progress curves. J. Mol.
Catal. B: Enzym. 2001, 13, 103–108.
(29) Shaw, W. H. R.; Raval, D. N. The inhibition of urease by metal
ions at pH 8.9. J. Am. Chem. Soc. 1961, 83, 3184–3187.
(30) Amtul, Z.; Atta-ur-Rahman; Siddiqui, R. A.; Choudhary, M. I.
Chemistry and mechanism of urease inhibition. Curr. Med. Chem.
2002, 9, 1323–1348.
ents for enzyme inhibitor leads. J. Comput.-Aided Mol. Des. 1992,
6, 593–606.
(52) Walker, C. V.; Caravatti, G.; Denholm, A. A.; Egerton, J.;
Faessler, A.; Furet, P.; Garcıa-Echeverrıa, C.; Gay, B.; Irving, E.;
´ ´
Jones, K.; Lambert, A.; Press, N. J.; Woods, J. Structure-based
design and synthesis of phosphinate isosteres of phosphotyrosine
for incorporation in Grb2-SH2 domain inhibitors. Part 2. Bioorg.
Med. Chem. Lett. 2000, 10, 2343–2343.
ꢀ
(53) Kiezbasinski, P.; Albrycht, M.; Łuczak, J.; Mikozajczyk, M. Enzy-
matic reactions in ionic liquids: lipase-catalysed kinetic resolu-
tion of racemic, P-chiral hydroxymethanephosphinates and hyd-
roxymethylphosphine oxides. Tetrahedron Asymm. 2002, 13, 735–
738.
(54) Majewska, P.; Doskocz, M.; Lejczak, B.; Kafarski, P. Enzymatic
resolution of R-hydroxyphosphinates with two stereogenic centres
and determination of absolute configuration of stereoisomers
obtained. Tetrahedron: Asymmetry 2009, 20, 1568–1574.
(55) Prishchenko, A. A.; Livantsov, M. V.; Novikova, O. P.; Livantsova, L. I.;
Petrosyan, V. S. Synthesis of functionalized 1-trimethylsiloxy-substituted
(31) Dominguez, M. J.; Sanmartin, C.; Font, M.; Palop, J. A.; San
Francisco, S.; Urrutia, O.; Houdusse, F.; Garcia-Mina, J. M. De-
sign, synthesis, and biological evaluation of phosphoramide deriva-
tives as urease inhibitors. J. Agric. Food Chem. 2008, 56, 3721–3731.